Biological role of granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) on cells of the myeloid lineage

Journal of Leukocyte Biology

Volumn 100, Issue 3, 2016, Pages 481-489

  Ushach, Irina ^a   Zlotnik, Albert ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytokines; Homeostasis; Inflammation

Indexed keywords

COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR RECEPTOR; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 34;

AUTOIMMUNE DISEASE; BIOLOGICAL FUNCTIONS; BONE MARROW CELL; CELL ACTIVATION; CELL DIFFERENTIATION; CELL LINEAGE; CLINICAL TRIAL (TOPIC); DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE; META ANALYSIS (TOPIC); MONOCYTE; NEOPLASM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RETICULOENDOTHELIAL SYSTEM; REVIEW; ANIMAL; IMMUNOLOGY; PHYSIOLOGY;

ANIMALS; CELL LINEAGE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MYELOID CELLS;

EID: 84985029819     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.3RU0316-144R     Document Type: Review

References (151)

1. Hamilton, J. A., Achuthan, A. (2013) Colony stimulating factors and myeloid cell biology in health and disease. Trends Immunol. 34, 81-89.
2. Hamilton, J. A. (2008) Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 8, 533-544.
3. Shibata, Y., Berclaz, P. Y., Chroneos, Z. C., Yoshida, M., Whitsett, J. A., Trapnell, B. C. (2001) GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity 15, 557-567.
4. Berclaz, P. Y., Shibata, Y., Whitsett, J. A., Trapnell, B. C. (2002) GM-CSF, via PU.1, regulates alveolar macrophage Fcgamma R-mediated phagocytosis and the IL-18/IFN-gamma-mediated molecular connection between innate and adaptive immunity in the lung. Blood 100, 4193-4200.
5. Bezbradica, J. S., Gordy, L. E., Stanic, A. K., Dragovic, S., Hill, T., Hawiger, J., Unutmaz, D., Van Kaer, L., Joyce, S. (2006) Granulocytemacrophage colony-stimulating factor regulates effector differentiation of invariant natural killer T cells during thymic ontogeny. Immunity 25, 487-497.
6. Greter, M., Helft, J., Chow, A., Hashimoto, D., Mortha, A., Agudo-Cantero, J., Bogunovic, M., Gautier, E. L., Miller, J., Leboeuf, M., Lu, G., Aloman, C., Brown, B. D., Pollard, J. W., Xiong, H., Randolph, G. J., Chipuk, J. E., Frenette, P. S., Merad, M. (2012) GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells. Immunity 36, 1031-1046.
7. Fancke, B., Suter, M., Hochrein, H., O’Keeffe, M. (2008) M-CSF: a novel plasmacytoid and conventional dendritic cell poietin. Blood 111, 150-159.
8. Fleetwood, A. J., Dinh, H., Cook, A. D., Hertzog, P. J., Hamilton, J. A. (2009) GM-CSF-and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling. J. Leukoc. Biol. 86, 411-421.
9. Martinez, F. O., Gordon, S. (2014) The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 6, 13.
10. Joshi, S., Singh, A. R., Zulcic, M., Bao, L., Messer, K., Ideker, T., Dutkowski, J., Durden, D. L. (2014) Rac2 controls tumor growth, metastasis and M1-M2 macrophage differentiation in vivo. PLoS One 9, e95893.
11. Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., Locati, M., Mantovani, A., Martinez, F. O., Mege, J. L., Mosser, D. M., Natoli, G., Saeij, J. P., Schultze, J. L., Shirey, K. A., Sica, A., Suttles, J., Udalova, I., van Ginderachter, J. A., Vogel, S. N., Wynn, T. A. (2014) Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41, 14-20.
12. Hume, D. A., MacDonald, K. P. (2012) Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. Blood 119, 1810-1820.
13. Pollard, J. W. (2009) Trophic macrophages in development and disease. Nat. Rev. Immunol. 9, 259-270.
14. McDermott, R. S., Deneux, L., Mosseri, V., Védrenne, J., Clough, K., Fourquet, A., Rodriguez, J., Cosset, J. M., Sastre, X., Beuzeboc, P., Pouillart, P., Scholl, S. M. (2002) Circulating macrophage colony stimulating factor as a marker of tumour progression. Eur. Cytokine Netw. 13, 121-127.
15. Scholl, S. M., Lidereau, R., de la Rochefordière, A., Le-Nir, C. C., Mosseri, V., Noguès, C., Pouillart, P., Stanley, F. R. (1996) Circulating levels of the macrophage colony stimulating factor CSF-1 in primary and metastatic breast cancer patients. A pilot study. Breast Cancer Res. Treat. 39, 275-283.
16. Firestein, G. S., Xu, W. D., Townsend, K., Broide, D., Alvaro-Gracia, J., Glasebrook, A., Zvaifler, N. J. (1988) Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis. J. Exp. Med. 168, 1573-1586.
17. Bischof, R. J., Zafiropoulos, D., Hamilton, J. A., Campbell, I. K. (2000) Exacerbation of acute inflammatory arthritis by the colony-stimulating factors CSF-1 and granulocyte macrophage (GM)-CSF: evidence of macrophage infiltration and local proliferation. Clin. Exp. Immunol. 119, 361-367.
18. Pollard, J. W., Bartocci, A., Arceci, R., Orlofsky, A., Ladner, M. B., Stanley, E. R. (1987) Apparent role of the macrophage growth factor, CSF-1, in placental development. Nature 330, 484-486.
19. Bartocci, A., Pollard, J. W., Stanley, E. R. (1986) Regulation of colonystimulating factor 1 during pregnancy. J. Exp. Med. 164, 956-961.
20. Bartocci, A., Mastrogiannis, D. S., Migliorati, G., Stockert, R. J., Wolkoff, A. W., Stanley, E. R. (1987) Macrophages specifically regulate the concentration of their own growth factor in the circulation. Proc. Natl. Acad. Sci. USA 84, 6179-6183.
21. Luo, J., Elwood, F., Britschgi, M., Villeda, S., Zhang, H., Ding, Z., Zhu, L., Alabsi, H., Getachew, R., Narasimhan, R., Wabl, R., Fainberg, N., James, M. L., Wong, G., Relton, J., Gambhir, S. S., Pollard, J. W., Wyss-Coray, T. (2013) Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival. J. Exp. Med. 210, 157-172.
22. Jin, S., Sonobe, Y., Kawanokuchi, J., Horiuchi, H., Cheng, Y., Wang, Y., Mizuno, T., Takeuchi, H., Suzumura, A. (2014) Interleukin-34 restores blood-brain barrier integrity by upregulating tight junction proteins in endothelial cells. PLoS One 9, e115981.
23. Pixley, F. J., Stanley, E. R. (2004) CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol. 14, 628-638.
24. Ryan, G. R., Dai, X. M., Dominguez, M. G., Tong, W., Chuan, F., Chisholm, O., Russell, R. G., Pollard, J. W., Stanley, E. R. (2001) Rescue of the colony-stimulating factor 1 (CSF-1)-nullizygous mouse (Csf1 (op)/Csf1(op)) phenotype with a CSF-1 transgene and identification of sites of local CSF-1 synthesis. Blood 98, 74-84.
25. Dai, X. M., Zong, X. H., Sylvestre, V., Stanley, E. R. (2004) Incomplete restoration of colony-stimulating factor 1 (CSF-1) function in CSF-1-deficient Csf1op/Csf1op mice by transgenic expression of cell surface CSF-1. Blood 103, 1114-1123.
26. Sasaki, A., Yokoo, H., Naito, M., Kaizu, C., Shultz, L. D., Nakazato, Y. (2000) Effects of macrophage-colony-stimulating factor deficiency on the maturation of microglia and brain macrophages and on their expression of scavenger receptor. Neuropathology 20, 134-142.
27. Gómez-Nicola, D., Fransen, N. L., Suzzi, S., Perry, V. H. (2013) Regulation of microglial proliferation during chronic neurodegeneration. J. Neurosci. 33, 2481-2493.
28. Yamamoto, T., Kaizu, C., Kawasaki, T., Hasegawa, G., Umezu, H., Ohashi, R., Sakurada, J., Jiang, S., Shultz, L., Naito, M. (2008) Macrophage colony-stimulating factor is indispensable for repopulation and differentiation of Kupffer cells but not for splenic red pulp macrophages in osteopetrotic (op/op) mice after macrophage depletion. Cell Tissue Res. 332, 245-256.
29. Dai, X. M., Ryan, G. R., Hapel, A. J., Dominguez, M. G., Russell, R. G., Kapp, S., Sylvestre, V., Stanley, E. R. (2002) Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 99, 111-120.
30. Hume, D. A., Pavli, P., Donahue, R. E., Fidler, I. J. (1988) The effect of human recombinant macrophage colony-stimulating factor (CSF-1) on the murine mononuclear phagocyte system in vivo. J. Immunol. 141, 3405-3409.
31. MacDonald, K. P., Rowe, V., Bofinger, H. M., Thomas, R., Sasmono, T., Hume, D. A., Hill, G. R. (2005) The colony-stimulating factor 1 receptor is expressed on dendritic cells during differentiation and regulates their expansion. J. Immunol. 175, 1399-1405.
32. Haan, C. K., Lazar, H. L., Rivers, S., Coady, C., Shemin, R. J. (1990) Improved myocardial preservation during cold storage using substrate enhancement. Ann. Thorac. Surg. 50, 80-85.
33. Ginhoux, F., Liu, K., Helft, J., Bogunovic, M., Greter, M., Hashimoto, D., Price, J., Yin, N., Bromberg, J., Lira, S. A., Stanley, E. R., Nussenzweig, M., Merad, M. (2009) The origin and development of nonlymphoid tissue CD103+ DCs. J. Exp. Med. 206, 3115-3130.
34. Auffray, C., Fogg, D. K., Narni-Mancinelli, E., Senechal, B., Trouillet, C., Saederup, N., Leemput, J., Bigot, K., Campisi, L., Abitbol, M., Molina, T., Charo, I., Hume, D. A., Cumano, A., Lauvau, G., Geissmann, F. (2009) CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation. J. Exp. Med. 206, 595-606.
35. Wiktor-Jedrzejczak, W., Urbanowska, E., Aukerman, S. L., Pollard, J. W., Stanley, E. R., Ralph, P., Ansari, A. A., Sell, K. W., Szperl, M. (1991) Correction by CSF-1 of defects in the osteopetrotic op/op mouse suggests local, developmental, and humoral requirements for this growth factor. Exp. Hematol. 19, 1049-1054.
36. Marks, S. C., Jr., Wojtowicz, A., Szperl, M., Urbanowska, E., MacKay, C. A., Wiktor-Jedrzejczak, W., Stanley, E. R., Aukerman, S. L. (1992) Administration of colony stimulating factor-1 corrects some macrophage, dental, and skeletal defects in an osteopetrotic mutation (toothless, tl) in the rat. Bone 13, 89-93.
37. Cohen, P. E., Zhu, L., Nishimura, K., Pollard, J. W. (2002) Colonystimulating factor 1 regulation of neuroendocrine pathways that control gonadal function in mice. Endocrinology 143, 1413-1422.
38. Michaelson, M. D., Bieri, P. L., Mehler, M. F., Xu, H., Arezzo, J. C., Pollard, J. W., Kessler, J. A. (1996) CSF-1 deficiency in mice results in abnormal brain development. Development 122, 2661-2672.
39. Cohen, P. E., Nishimura, K., Zhu, L., Pollard, J. W. (1999) Macrophages: important accessory cells for reproductive function. J. Leukoc. Biol. 66, 765-772.
40. Mabbott, N. A., Kenneth Baillie, J., Hume, D. A., Freeman, T. C. (2010) Meta-analysis of lineage-specific gene expression signatures in mouse leukocyte populations. Immunobiology 215, 724-736.
41. Ushach, I., Burkhardt, A. M., Martinez, C., Hevezi, P. A., Gerber, P. A., Buhren, B. A., Schrumpf, H., Valle-Rios, R., Vazquez, M. I., Homey, B., Zlotnik, A. (2015) Meteorin-like is a cytokine associated with barrier tissues and alternatively activated macrophages. Clin. Immunol. 156, 119-127.
42. Rademakers, R., Baker, M., Nicholson, A. M., Rutherford, N. J., Finch, N., Soto-Ortolaza, A., Lash, J., Wider, C., Wojtas, A., DeJesus-Hernandez, M., Adamson, J., Kouri, N., Sundal, C., Shuster, E. A., Aasly, J., MacKenzie, J., Roeber, S., Kretzschmar, H. A., Boeve, B. F., Knopman, D. S., Petersen, R. C., Cairns, N. J., Ghetti, B., Spina, S., Garbern, J., Tselis, A. C., Uitti, R., Das, P., Van Gerpen, J. A., Meschia, J. F., Levy, S., Broderick, D. F., Graff-Radford, N., Ross, O. A., Miller, B. B., Swerdlow, R. H., Dickson, D. W., Wszolek, Z. K. (2011) Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat. Genet. 44, 200-205.
43. Tobal, K., Pagliuca, A., Bhatt, B., Bailey, N., Layton, D. M., Mufti, G. J. (1990) Mutation of the human FMS gene (M-CSF receptor) in myelodysplastic syndromes and acute myeloid leukemia. Leukemia 4, 486-489.
44. Wei, S., Nandi, S., Chitu, V., Yeung, Y. G., Yu, W., Huang, M., Williams, L. T., Lin, H., Stanley, E. R. (2010) Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells. J. Leukoc. Biol. 88, 495-505.
45. Lin, H., Lee, E., Hestir, K., Leo, C., Huang, M., Bosch, E., Halenbeck, R., Wu, G., Zhou, A., Behrens, D., Hollenbaugh, D., Linnemann, T., Qin, M., Wong, J., Chu, K., Doberstein, S. K., Williams, L. T. (2008) Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 320, 807-811.
46. Foucher, E. D., Blanchard, S., Preisser, L., Garo, E., Ifrah, N., Guardiola, P., Delneste, Y., Jeannin, P. (2013) IL-34 induces the differentiation of human monocytes into immunosuppressive macrophages. antagonistic effects of GM-CSF and IFNg. PLoS One 8, e56045.
47. Wang, Y., Szretter, K. J., Vermi, W., Gilfillan, S., Rossini, C., Cella, M., Barrow, A. D., Diamond, M. S., Colonna, M. (2012) IL-34 is a tissuerestricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat. Immunol. 13, 753-760.
48. Greter, M., Lelios, I., Pelczar, P., Hoeffel, G., Price, J., Leboeuf, M., Kündig, T. M., Frei, K., Ginhoux, F., Merad, M., Becher, B. (2012) Stroma-derived interleukin-34 controls the development and maintenance of Langerhans cells and the maintenance of microglia. Immunity 37, 1050-1060.
49. Nandi, S., Gokhan, S., Dai, X. M., Wei, S., Enikolopov, G., Lin, H., Mehler, M. F., Stanley, E. R. (2012) The CSF-1 receptor ligands IL-34 and CSF-1 exhibit distinct developmental brain expression patterns and regulate neural progenitor cell maintenance and maturation. Dev. Biol. 367, 100-113.
50. Wang, Y., Bugatti, M., Ulland, T. K., Vermi, W., Gilfillan, S., Colonna, M. (2016) Nonredundant roles of keratinocyte-derived IL-34 and neutrophil-derived CSF1 in Langerhans cell renewal in the steady state and during inflammation. Eur. J. Immunol. 46, 552-559.
51. Garceau, V., Smith, J., Paton, I. R., Davey, M., Fares, M. A., Sester, D. P., Burt, D.W., Hume, D. A. (2010) Pivotal Advance: Avian colony-stimulating factor 1 (CSF-1), interleukin-34 (IL-34), and CSF-1 receptor genes and gene products. J. Leukoc. Biol. 87, 753-764.
52. Nandi, S., Cioce, M., Yeung, Y. G., Nieves, E., Tesfa, L., Lin, H., Hsu, A. W., Halenbeck, R., Cheng, H. Y., Gokhan, S., Mehler, M. F., Stanley, E. R. (2013) Receptor-type protein-tyrosine phosphatase z is a functional receptor for interleukin-34. J. Biol. Chem. 288, 21972-21986.
53. Bézie, S., Picarda, E., Ossart, J., Tesson, L., Usal, C., Renaudin, K., Anegon, I., Guillonneau, C. (2015) IL-34 is a Treg-specific cytokine and mediates transplant tolerance. J. Clin. Invest. 125, 3952-3964.
54. Chang, E. J., Lee, S. K., Song, Y. S., Jang, Y. J., Park, H. S., Hong, J. P., Ko, A. R., Kim, D. Y., Kim, J. H., Lee, Y. J., Heo, Y. S. (2014) IL-34 is associated with obesity, chronic inflammation, and insulin resistance. J. Clin. Endocrinol. Metab. 99, E1263-E1271.
55. Preisser, L., Miot, C., Le Guillou-Guillemette, H., Beaumont, E., Foucher, E. D., Garo, E., Blanchard, S., Frémaux, I., Croué, A., Fouchard, I., Lunel-Fabiani, F., Boursier, J., Roingeard, P., Calès, P., Delneste, Y., Jeannin, P. (2014) IL-34 and macrophage colonystimulating factor are overexpressed in hepatitis C virus fibrosis and induce profibrotic macrophages that promote collagen synthesis by hepatic stellate cells. Hepatology 60, 1879-1890.
56. Ségaliny, A. I., Mohamadi, A., Dizier, B., Lokajczyk, A., Brion, R., Lanel, R., Amiaud, J., Charrier, C., Boisson-Vidal, C., Heymann, D. (2015) Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment. Int. J. Cancer 137, 73-85.
57. Zwicker, S., Martinez, G. L., Bosma, M., Gerling, M., Clark, R., Majster, M., Söderman, J., Almer, S., Boström, E. A. (2015) Interleukin 34: a new modulator of human and experimental inflammatory bowel disease. Clin. Sci. 129, 281-290.
58. Toh, M. L., Bonnefoy, J. Y., Accart, N., Cochin, S., Pohle, S., Haegel, H., De Meyer, M., Zemmour, C., Preville, X., Guillen, C., Thioudellet, C., Ancian, P., Lux, A., Sehnert, B., Nimmerjahn, F., Voll, R. E., Schett, G. (2014) Bone-and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis. Arthritis Rheumatol. 66, 2989-3000.
59. Menke, J., Iwata, Y., Rabacal, W. A., Basu, R., Stanley, E. R., Kelley, V. R. (2011) Distinct roles of CSF-1 isoforms in lupus nephritis. J. Am. Soc. Nephrol. 22, 1821-1833.
60. Chitu, V., Stanley, E. R. (2006) Colony-stimulating factor-1 in immunity and inflammation. Curr. Opin. Immunol. 18, 39-48.
61. Ohno, H., Uemura, Y., Murooka, H., Takanashi, H., Tokieda, T., Ohzeki, Y., Kubo, K., Serizawa, I. (2008) The orally-active and selective c-Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen-induced arthritis mouse model. Eur. J. Immunol. 38, 283-291.
62. Conway, J. G., Pink, H., Bergquist, M. L., Han, B., Depee, S., Tadepalli, S., Lin, P., Crumrine, R. C., Binz, J., Clark, R. L., Selph, J. L., Stimpson, S. A., Hutchins, J. T., Chamberlain, S. D., Brodie, T. A. (2008) Effects of the cFMS kinase inhibitor 5-(3-methoxy-4-((4-methoxybenzyl)oxy) benzyl)pyrimidine-2,4-diamine (GW2580) in normal and arthritic rats. J. Pharmacol. Exp. Ther. 326, 41-50.
63. Manthey, C. L., Johnson, D. L., Illig, C. R., Tuman, R. W., Zhou, Z., Baker, J. F., Chaikin, M. A., Donatelli, R. R., Franks, C. F., Zeng, L., Crysler, C., Chen, Y., Yurkow, E. J., Boczon, L., Meegalla, S. K., Wilson, K. J., Wall, M. J., Chen, J., Ballentine, S. K., Ott, H., Baumann, C., Lawrence, D., Tomczuk, B. E., Molloy, C. J. (2009) JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia. Mol. Cancer Ther. 8, 3151-3161.
64. Kubota, Y., Takubo, K., Shimizu, T., Ohno, H., Kishi, K., Shibuya, M., Saya, H., Suda, T. (2009) M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis. J. Exp. Med. 206, 1089-1102.
65. Han, Y., Ma, F. Y., Tesch, G. H., Manthey, C. L., Nikolic-Paterson, D. J. (2011) c-fms blockade reverses glomerular macrophage infiltration and halts development of crescentic anti-GBM glomerulonephritis in the rat. Lab. Invest. 91, 978-991.
66. Shaposhnik, Z., Wang, X., Lusis, A. J. (2010) Arterial colony stimulating factor-1 influences atherosclerotic lesions by regulating monocyte migration and apoptosis. J. Lipid Res. 51, 1962-1970.
67. Menke, J., Rabacal, W. A., Byrne, K. T., Iwata, Y., Schwartz, M. M., Stanley, E. R., Schwarting, A., Kelley, V. R. (2009) Circulating CSF-1 promotes monocyte and macrophage phenotypes that enhance lupus nephritis. J. Am. Soc. Nephrol. 20, 2581-2592.
68. Sawanobori, Y., Ueha, S., Kurachi, M., Shimaoka, T., Talmadge, J. E., Abe, J., Shono, Y., Kitabatake, M., Kakimi, K., Mukaida, N., Matsushima, K. (2008) Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice. Blood 111, 5457-5466.
69. Noy, R., Pollard, J. W. (2014) Tumor-associated macrophages: from mechanisms to therapy. Immunity 41, 49-61.
70. Qian, B. Z., Pollard, J. W. (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141, 39-51.
71. Lin, E. Y., Nguyen, A. V., Russell, R. G., Pollard, J. W. (2001) Colonystimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 193, 727-740.
72. Zhang, Q. W., Liu, L., Gong, C. Y., Shi, H. S., Zeng, Y. H., Wang, X. Z., Zhao, Y. W., Wei, Y. Q. (2012) Prognostic significance of tumorassociated macrophages in solid tumor: a meta-analysis of the literature. PLoS One 7, e50946.
73. Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C., Quick, M. L., Huse, J. T., Teijeiro, V., Setty, M., Leslie, C. S., Oei, Y., Pedraza, A., Zhang, J., Brennan, C. W., Sutton, J. C., Holland, E. C., Daniel, D., Joyce, J. A. (2013) CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat. Med. 19, 1264-1272.
74. Zhu, Y., Knolhoff, B. L., Meyer, M. A., Nywening, T. M., West, B. L., Luo, J., Wang-Gillam, A., Goedegebuure, S. P., Linehan, D. C., DeNardo, D. G. (2014) CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. Cancer Res. 74, 5057-5069.
75. Strachan, D. C., Ruffell, B., Oei, Y., Bissell, M. J., Coussens, L. M., Pryer, N., Daniel, D. (2013) CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumorassociated macrophages and enhancing infiltration by CD8(+) T cells. OncoImmunology 2, e26968.
76. Genovese, M. C., Hsia, E., Belkowski, S. M., Chien, C., Masterson, T., Thurmond, R. L., Manthey, C. L., Yan, X. D., Ge, T., Franks, C., Greenspan, A. (2015) Results from a Phase IIA parallel group study of JNJ-40346527, an oral CSF-1R inhibitor, in patients with active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy. J. Rheumatol. 42, 1752-1760.
77. Butowski, N., Colman, H., De Groot, J. F., Omuro, A. M., Nayak, L., Wen, P. Y., Cloughesy, T. F., Marimuthu, A., Haidar, S., Perry, A., Huse, J., Phillips, J., West, B. L., Nolop, K. B., Hsu, H. H., Ligon, K. L., Molinaro, A. M., Prados, M. (2015) Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium Phase II study. Neuro-oncol. 18, 557-564.
78. Ries, C. H., Hoves, S., Cannarile, M. A., Rüttinger, D. (2015) CSF-1/CSF-1R targeting agents in clinical development for cancer therapy. Curr. Opin. Pharmacol. 23, 45-51.
79. Tap, W. D., Wainberg, Z. A., Anthony, S. P., Ibrahim, P. N., Zhang, C., Healey, J. H., Chmielowski, B., Staddon, A. P., Cohn, A. L., Shapiro, G. I., Keedy, V. L., Singh, A. S., Puzanov, I., Kwak, E. L., Wagner, A. J., Von Hoff, D. D., Weiss, G. J., Ramanathan, R. K., Zhang, J., Habets, G., Zhang, Y., Burton, E. A., Visor, G., Sanftner, L., Severson, P., Nguyen, H., Kim, M. J., Marimuthu, A., Tsang, G., Shellooe, R., Gee, C., West, B. L., Hirth, P., Nolop, K., van de Rijn, M., Hsu, H. H., Peterfy, C., Lin, P. S., Tong-Starksen, S., Bollag, G. (2015) Structure-guided blockade of CSF1R kinase in tenosynovial giant-cell tumor. N. Engl. J. Med. 373, 428-437.
80. Williamson, D. J., Begley, C. G., Vadas, M. A., Metcalf, D. (1988) The detection and initial characterization of colony-stimulating factors in synovial fluid. Clin. Exp. Immunol. 72, 67-73.
81. Sheridan, J. W., Metcalf, D. (1972) Studies on the bone marrow colony stimulating factor (CSF): relation of tissue CSF to serum CSF. J. Cell. Physiol. 80, 129-140.
82. Zucali, J. R., Dinarello, C. A., Oblon, D. J., Gross, M. A., Anderson, L., Weiner, R. S. (1986) Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2. J. Clin. Invest. 77, 1857-1863.
83. Bagby, G. C., Jr., Dinarello, C. A., Wallace, P., Wagner, C., Hefeneider, S., McCall, E. (1986) Interleukin 1 stimulates granulocyte macrophage colony-stimulating activity release by vascular endothelial cells. J. Clin. Invest. 78, 1316-1323.
84. Gasson, J. C. (1991) Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 77, 1131-1145.
85. Lukens, J. R., Barr, M. J., Chaplin, D. D., Chi, H., Kanneganti, T. D. (2012) Inflammasome-derived IL-1b regulates the production of GM-CSF by CD4(+) T cells and gd T cells. J. Immunol. 188, 3107-3115.
86. El-Behi, M., Ciric, B., Dai, H., Yan, Y., Cullimore, M., Safavi, F., Zhang, G. X., Dittel, B. N., Rostami, A. (2011) The encephalitogenicity of T(H) 17 cells is dependent on IL-1-and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 12, 568-575.
87. Jansen, J. H., Wientjens, G. J., Fibbe, W. E., Willemze, R., Kluin-Nelemans, H. C. (1989) Inhibition of human macrophage colony formation by interleukin 4. J. Exp. Med. 170, 577-582.
88. Ozawa, H., Aiba, S., Nakagawa, Tagami H. (1996) Interferon-gamma and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7-1) expression. Eur. J. Immunol. 26, 648-652.
89. Sagawa, K., Mochizuki, M., Sugita, S., Nagai, K., Sudo, T., Itoh, K. (1996) Suppression by IL-10 and IL-4 of cytokine production induced by two-way autologous mixed lymphocyte reaction. Cytokine 8, 501-506.
90. Hamilton, J. A. (1993) Rheumatoid arthritis: opposing actions of haemopoietic growth factors and slow-acting anti-rheumatic drugs. Lancet 342, 536-539.
91. Ponomarev, E. D., Shriver, L. P., Maresz, K., Pedras-Vasconcelos, J., Verthelyi, D., Dittel, B. N. (2007) GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis. J. Immunol. 178, 39-48.
92. Parajuli, B., Sonobe, Y., Kawanokuchi, J., Doi, Y., Noda, M., Takeuchi, H., Mizuno, T., Suzumura, A. (2012) GM-CSF increases LPS-induced production of proinflammatory mediators via upregulation of TLR4 and CD14 in murine microglia. J. Neuroinflammation 9, 268.
93. Hamilton, J. A., Tak, P. P. (2009) The dynamics of macrophage lineage populations in inflammatory and autoimmune diseases. Arthritis Rheum. 60, 1210-1221.
94. Zhu, S. N., Chen, M., Jongstra-Bilen, J., Cybulsky, M. I. (2009) GM-CSF regulates intimal cell proliferation in nascent atherosclerotic lesions. J. Exp. Med. 206, 2141-2149.
95. Cook, A. D., Turner, A. L., Braine, E. L., Pobjoy, J., Lenzo, J. C., Hamilton, J. A. (2011) Regulation of systemic and local myeloid cell subpopulations by bonemarrow cell-derived granulocyte-macrophage colony-stimulating factor in experimental inflammatory arthritis. Arthritis Rheum. 63, 2340-2351.
96. Shinohara, H., Yano, S., Bucana, C. D., Fidler, I. J. (2000) Induction of chemokine secretion and enhancement of contact-dependent macrophage cytotoxicity by engineered expression of granulocytemacrophage colony-stimulating factor in human colon cancer cells. J. Immunol. 164, 2728-2737.
97. Fleetwood, A. J., Lawrence, T., Hamilton, J. A., Cook, A. D. (2007) Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J. Immunol. 178, 5245-5252.
98. Lacey, D. C., Achuthan, A., Fleetwood, A. J., Dinh, H., Roiniotis, J., Scholz, G. M., Chang, M. W., Beckman, S. K., Cook, A. D., Hamilton, J. A. (2012) Defining GM-CSF-and macrophage-CSF-dependent macrophage responses by in vitro models. J. Immunol. 188, 5752-5765.
99. Paine, R., III, Morris, S. B., Jin, H., Wilcoxen, S. E., Phare, S. M., Moore, B. B., Coffey, M. J., Toews, G. B. (2001) Impaired functional activity of alveolar macrophages from GM-CSF-deficient mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 281, L1210-L1218.
100. Lari, R., Fleetwood, A. J., Kitchener, P. D., Cook, A. D., Pavasovic, D., Hertzog, P. J., Hamilton, J. A. (2007) Macrophage lineage phenotypes and osteoclastogenesis—complexity in the control by GM-CSF and TGFbeta. Bone 40, 323-336.
101. Krausgruber, T., Blazek, K., Smallie, T., Alzabin, S., Lockstone, H., Sahgal, N., Hussell, T., Feldmann, M., Udalova, I. A. (2011) IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat. Immunol. 12, 231-238.
102. Sierra-Filardi, E., Puig-Kröger, A., Blanco, F. J., Nieto, C., Bragado, R., Palomero, M. I., Bernabéu, C., Vega, M. A., Corbí, A. L. (2011) Activin A skews macrophage polarization by promoting a proinflammatory phenotype and inhibiting the acquisition of anti-inflammatory macrophage markers. Blood 117, 5092-5101.
103. Dirksen, U., Nishinakamura, R., Groneck, P., Hattenhorst, U., Nogee, L., Murray, R., Burdach, S. (1997) Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression. J. Clin. Invest. 100, 2211-2217.
104. Dirksen, U., Hattenhorst, U., Schneider, P., Schroten, H., Göbel, U., Böcking, A., Müller, K. M., Murray, R., Burdach, S. (1998) Defective expression of granulocyte-macrophage colony-stimulating factor/ interleukin-3/interleukin-5 receptor common beta chain in children with acute myeloid leukemia associated with respiratory failure. Blood 92, 1097-1103.
105. King, I. L., Kroenke, M. A., Segal, B. M. (2010) GM-CSF-dependent, CD103+ dermal dendritic cells play a critical role in Th effector cell differentiation after subcutaneous immunization. J. Exp. Med. 207, 953-961.
106. Bogunovic, M., Ginhoux, F., Helft, J., Shang, L., Hashimoto, D., Greter, M., Liu, K., Jakubzick, C., Ingersoll, M. A., Leboeuf, M., Stanley, E. R., Nussenzweig, M., Lira, S. A., Randolph, G. J., Merad, M. (2009) Origin of the lamina propria dendritic cell network. Immunity 31, 513-525.
107. Daro, E., Pulendran, B., Brasel, K., Teepe, M., Pettit, D., Lynch, D. H., Vremec, D., Robb, L., Shortman, K., McKenna, H. J., Maliszewski, C. R., Maraskovsky, E. (2000) Polyethylene glycol-modified GM-CSF expands CD11b(high)CD11c(high) but notCD11b(low)CD11c(high) murine dendritic cells in vivo: a comparative analysis with Flt3 ligand. J. Immunol. 165, 49-58.
108. Zhan, Y., Xu, Y., Lew, A. M. (2012) The regulation of the development and function of dendritic cell subsets by GM-CSF: more than a hematopoietic growth factor. Mol. Immunol. 52, 30-37.
109. Domínguez, P. M., Ardavín, C. (2010) Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation. Immunol. Rev. 234, 90-104.
110. Shortman, K., Naik, S. H. (2007) Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 7, 19-30.
111. Martinez-Moczygemba, M., Huston, D. P. (2003) Biology of common beta receptor-signaling cytokines: IL-3, IL-5, and GM-CSF. J. Allergy Clin. Immunol. 112, 653-665, quiz 666.
112. Bazan, J. F. (1990) Haemopoietic receptors and helical cytokines. Immunol. Today 11, 350-354.
113. Rozwarski, D. A., Gronenborn, A. M., Clore, G. M., Bazan, J. F., Bohm, A., Wlodawer, A., Hatada, M., Karplus, P. A. (1994) Structural comparisons among the short-chain helical cytokines. Structure 2, 159-173.
114. Van Leeuwen, B. H., Martinson, M. E., Webb, G. C., Young, I. G. (1989) Molecular organization of the cytokine gene cluster, involving the human IL-3, IL-4, IL-5, and GM-CSF genes, on human chromosome 5. Blood 73, 1142-1148.
115. Guthridge, M. A., Stomski, F. C., Thomas, D., Woodcock, J. M., Bagley, C. J., Berndt, M. C., Lopez, A. F. (1998) Mechanism of activation of the GM-CSF, IL-3, and IL-5 family of receptors. Stem Cells 16, 301-313.
116. De Groot, R. P., Coffer, P. J., Koenderman, L. (1998) Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family. Cell. Signal. 10, 619-628.
117. Scott, C. L., Begley, C. G. (1999) The beta common chain (beta c) of the granulocyte macrophage-colony stimulating factor, interleukin-3 and interleukin-5 receptors. Int. J. Biochem. Cell Biol. 31, 1011-1015.
118. Woodcock, J. M., Bagley, C. J., Lopez, A. F. (1999) The functional basis of granulocyte-macrophage colony stimulating factor, interleukin-3 and interleukin-5 receptor activation, basic and clinical implications. Int. J. Biochem. Cell Biol. 31, 1017-1025.
119. Brown, A. L., Salerno, D. G., Sadras, T., Engler, G. A., Kok, C. H., Wilkinson, C. R., Samaraweera, S. E., Sadlon, T. J., Perugini, M., Lewis, I. D., Gonda, T. J., D’Andrea, R. J. (2012) The GM-CSF receptor utilizes b-catenin and Tcf4 to specify macrophage lineage differentiation. Differentiation 83, 47-59.
120. Burgess, A. W., Camakaris, J., Metcalf, D. (1977) Purification and properties of colony-stimulating factor from mouse lung-conditioned medium. J. Biol. Chem. 252, 1998-2003.
121. Paine, R., III, Preston, A. M., Wilcoxen, S., Jin, H., Siu, B. B., Morris, S. B., Reed, J. A., Ross, G., Whitsett, J. A., Beck, J. M. (2000) Granulocytemacrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice. J. Immunol. 164, 2602-2609.
122. LeVine, A. M., Reed, J. A., Kurak, K. E., Cianciolo, E., Whitsett, J. A. (1999) GM-CSF-deficient mice are susceptible to pulmonary group B streptococcal infection. J. Clin. Invest. 103, 563-569.
123. Hirata, Y., Egea, L., Dann, S. M., Eckmann, L., Kagnoff, M. F. (2010) GM-CSF-facilitated dendritic cell recruitment and survival govern the intestinal mucosal response to a mouse enteric bacterial pathogen. Cell Host Microbe 7, 151-163.
124. McGeachy, M. J. (2011) GM-CSF: the secret weapon in the T(H)17 arsenal. Nat. Immunol. 12, 521-522.
125. Codarri, L., Gy ülvészi, G., Tosevski, V., Hesske, L., Fontana, A., Magnenat, L., Suter, T., Becher, B. (2011) RORgt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12, 560-567.
126. Cousins, D. J., Lee, T. H., Staynov, D. Z. (2002) Cytokine coexpression during human Th1/Th2 cell differentiation: direct evidence for coordinated expression of Th2 cytokines. J. Immunol. 169, 2498-2506.
127. Fong, T. A., Mosmann, T. R. (1990) Alloreactive murine CD8+ T cell clones secrete the Th1 pattern of cytokines. J. Immunol. 144, 1744-1752.
128. Bacchetta, R., de Waal Malefijt, R., Yssel, H., Abrams, J., de Vries, J. E., Spits, H., Roncarolo, M. G. (1990) Host-reactive CD4+ and CD8+ T cell clones isolated from a human chimera produce IL-5, IL-2, IFN-gamma and granulocyte/macrophage-colony-stimulating factor but not IL-4. J. Immunol. 144, 902-908.
129. Shi, Y., Liu, C. H., Roberts, A. I., Das, J., Xu, G., Ren, G., Zhang, Y., Zhang, L., Yuan, Z. R., Tan, H. S., Das, G., Devadas, S. (2006) Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don’t know. Cell Res. 16, 126-133.
130. Young, A., Linehan, E., Hams, E., O’Hara Hall, A. C., McClurg, A., Johnston, J. A., Hunter, C. A., Fallon, P. G., Fitzgerald, D. C. (2012) Cutting edge: suppression of GM-CSF expression in murine and human T cells by IL-27. J. Immunol. 189, 2079-2083.
131. Wada, H., Noguchi, Y., Marino, M. W., Dunn, A. R., Old, L. J. (1997) T cell functions in granulocyte/macrophage colony-stimulating factor deficient mice. Proc. Natl. Acad. Sci. USA 94, 12557-12561.
132. Gonzalez-Juarrero, M., Hattle, J. M., Izzo, A., Junqueira-Kipnis, A. P., Shim, T. S., Trapnell, B. C., Cooper, A. M., Orme, I. M. (2005) Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection. J. Leukoc. Biol. 77, 914-922.
133. Barouch, D. H., Santra, S., Tenner-Racz, K., Racz, P., Kuroda, M. J., Schmitz, J. E., Jackson, S. S., Lifton, M. A., Freed, D. C., Perry, H. C., Davies, M. E., Shiver, J. W., Letvin, N. L. (2002) Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF. J. Immunol. 168, 562-568.
134. Baiocchi, R. A., Ward, J. S., Carrodeguas, L., Eisenbeis, C. F., Peng, R., Roychowdhury, S., Vourganti, S., Sekula, T., O’Brien, M., Moeschberger, M., Caligiuri, M. A. (2001) GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorder. J. Clin. Invest. 108, 887-894.
135. Colotta, F., Bussolino, F., Polentarutti, N., Guglielmetti, A., Sironi, M., Bocchietto, E., De Rossi, M., Mantovani, A. (1993) Differential expression of the common beta and specific alpha chains of the receptors for GM-CSF, IL-3, and IL-5 in endothelial cells. Exp. Cell Res. 206, 311-317.
136. Rosas, M., Gordon, S., Taylor, P. R. (2007) Characterisation of the expression and function of the GM-CSF receptor alpha-chain in mice. Eur. J. Immunol. 37, 2518-2528.
137. Min, L., Mohammad Isa, S. A., Shuai, W., Piang, C. B., Nih, F. W., Kotaka, M., Ruedl, C. (2010) Cutting edge: granulocyte-macrophage colony-stimulating factor is the major CD8+ T cell-derived licensing factor for dendritic cell activation. J. Immunol. 184, 4625-4629.
138. Weber, G. F., Chousterman, B. G., Hilgendorf, I., Robbins, C. S., Theurl, I., Gerhardt, L. M., Iwamoto, Y., Quach, T. D., Ali, M., Chen, J. W., Rothstein, T. L., Nahrendorf, M., Weissleder, R., Swirski, F. K. (2014) Pleural innate response activator B cells protect against pneumonia via a GM-CSF-IgM axis. J. Exp. Med. 211, 1243-1256.
139. Folman, R., Grenier, D., Birken, C., Campisi, P., Do, M. T., Forte, V., Maclusky, I., McCrindle, B. W., Narang, I., Witmans, M. (2013) Obesity hypoventilation syndrome: a different beast. Paediatr. Child Health 18, 36.
140. Nakae, S., Nambu, A., Sudo, K., Iwakura, Y. (2003) Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 171, 6173-6177.
141. Hofstetter, H. H., Ibrahim, S. M., Koczan, D., Kruse, N., Weishaupt, A., Toyka, K. V., Gold, R. (2005) Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell. Immunol. 237, 123-130.
142. Shiomi, A., Usui, T., Ishikawa, Y., Shimizu, M., Murakami, K., Mimori, T. (2014) GM-CSF but not IL-17 is critical for the development of severe interstitial lung disease in SKG mice. J. Immunol. 193, 849-859.
143. Ghoreschi, K., Laurence, A., Yang, X. P., Tato, C. M., McGeachy, M. J., Konkel, J. E., Ramos, H. L., Wei, L., Davidson, T. S., Bouladoux, N., Grainger, J. R., Chen, Q., Kanno, Y., Watford, W. T., Sun, H. W., Eberl, G., Shevach, E. M., Belkaid, Y., Cua, D. J., Chen, W., O’Shea, J. J. (2010) Generation of pathogenic T(H)17 cells in the absence of TGF-b signalling. Nature 467, 967-971.
144. Duhen, T., Campbell, D. J. (2014) IL-1b promotes the differentiation of polyfunctional human CCR6+CXCR3+ Th1/17 cells that are specific for pathogenic and commensal microbes. J. Immunol. 193, 120-129.
145. Acosta-Rodriguez, E. V., Rivino, L., Geginat, J., Jarrossay, D., Gattorno, M., Lanzavecchia, A., Sallusto, F., Napolitani, G. (2007) Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8, 639-646.
146. Campbell, I. K., Rich, M. J., Bischof, R. J., Dunn, A. R., Grail, D., Hamilton, J. A. (1998) Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice. J. Immunol. 161, 3639-3644.
147. McQualter, J. L., Darwiche, R., Ewing, C., Onuki, M., Kay, T. W., Hamilton, J. A., Reid, H. H., Bernard, C. C. (2001) Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J. Exp. Med. 194, 873-882.
148. Sonderegger, I., Iezzi, G., Maier, R., Schmitz, N., Kurrer, M., Kopf, M. (2008) GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival. J. Exp. Med. 205, 2281-2294.
149. Cook, A. D., Braine, E. L., Campbell, I. K., Rich, M. J., Hamilton, J. A. (2001) Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease. Arthritis Res. 3, 293-298.
150. Behrens, F., Tak, P. P., Østergaard, M., Stoilov, R., Wiland, P., Huizinga, T. W., Berenfus, V. Y., Vladeva, S., Rech, J., Rubbert-Roth, A., Korkosz, M., Rekalov, D., Zupanets, I. A., Ejbjerg, B. J., Geiseler, J., Fresenius, J., Korolkiewicz, R. P., Schottelius, A. J., Burkhardt, H. (2015) MOR103, a human monoclonal antibody to granulocyte-macrophage colonystimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, doubleblind, placebo-controlled, dose-escalation trial. Ann. Rheum. Dis. 74, 1058-1064.
151. Takeuchi, T., Tanaka, Y., Close, D., Godwood, A., Wu, C. Y., Saurigny, D. (2015) Efficacy and safety of mavrilimumab in Japanese subjects with rheumatoid arthritis: findings from a Phase IIa study. Mod. Rheumatol. 25, 21-30.